Novo Nordisk expands 90-day free insulin program to workers affected by COVID-19

Novo Nordisk will now provide a free 90-day supply of insulin through its Diabetes Patient Assistance Program to eligible patients with diabetes who have lost their healthcare access due to COVID-19, the drugmaker said Tuesday.